<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>Dimenhydrinate - Medications - Offline Clinical Reference</title>
  <link rel="stylesheet" href="../style.css">
</head>
<body>
  <div class="topbar">
    <div class="topbar-inner">
      <span class="pill"><strong>Dimenhydrinate</strong></span>
      <span class="spacer"></span>
      <div class="nav-btns">
        <a class="btn small" href="../index.html">Home</a>
        <a class="btn small" href="../medications.html">Back to Medications</a>
      </div>
    </div>
  </div>

  <main class="wrap">
    <section class="section">
      <div class="kicker">Neuro / Psych</div>
      <h1>Dimenhydrinate</h1>

      <div class="content">
        <h3>Stocked on board</h3>
        <ul>
          <li>Dimenhydrinate 50mg Injection 5mL</li>
          <li>Dimenhydrinate 50mg Tablets (Prepack 25-30)</li>
          <li>Dimenhydrinate Caplets</li>
        </ul>

        <div class="rule"></div>

        <h3>Adult dosing</h3>
        <ul>
          <li><strong>Motion sickness (prevention/treatment)</strong>
            <ul>
              <li>50–100 mg PO every 4 hours as needed (max 400 mg in 24 hours)</li>
              <li>For prevention: take at least 30 minutes before travel (ideally 1–2 hours before)</li>
            </ul>
          </li>
          <li><strong>Nausea/vomiting (moderate–severe; when oral not tolerated or faster onset needed)</strong>
            <ul>
              <li>25–50 mg IV/IM every 4–6 hours as needed</li>
              <li>If older/frail: consider 12.5 mg IV/IM every 4–6 hours as needed (delirium risk)</li>
            </ul>
          </li>
          <li><strong>Opioid-associated nausea (protocol-dependent)</strong>
            <ul>
              <li>Same as nausea/vomiting dosing above; reassess need as opioid dosing changes</li>
            </ul>
          </li>
        </ul>

        <div class="rule"></div>

        <h3>Indications</h3>
        <ul>
          <li>Prevention and treatment of nausea/vomiting/dizziness due to motion sickness</li>
          <li>Symptomatic relief of moderate–severe nausea and vomiting</li>
          <li>Antiemetic option for opioid-associated nausea (context/protocol dependent)</li>
        </ul>

        <div class="rule"></div>

        <h3>Contraindications / cautions</h3>
        <ul>
          <li>Hypersensitivity to dimenhydrinate/diphenhydramine (and related antihistamines)</li>
          <li>Sedation / impaired performance risk (esp. watchkeepers, machinery, ladders, weapons handling)</li>
          <li>Anticholinergic cautions: glaucoma/increased ocular pressure, urinary retention/BPH, severe constipation/ileus risk</li>
          <li>Caution in asthma/COPD (drying/thickened secretions), cardiovascular disease, and older adults (delirium/falls)</li>
          <li>Avoid combining with other sedatives/CNS depressants when possible (alcohol, benzodiazepines, opioids)</li>
        </ul>

        <div class="rule"></div>

        <h3>Adverse effects</h3>
        <ul>
          <li>Drowsiness, dizziness, impaired coordination</li>
          <li>Dry mouth, blurred vision, urinary retention, constipation</li>
          <li>Confusion/delirium (higher risk in older/frail; dose related)</li>
        </ul>

        <div class="rule"></div>

        <h3>Preparation &amp; administration</h3>
        <ul>
          <li>PO: use lowest effective dose; counsel re: sedation</li>
          <li>IV/IM: administer per local protocol; monitor for sedation/hypotension</li>
          <li>Reassess after dose; avoid stacking with other sedating agents unless necessary</li>
        </ul>

        <div class="rule"></div>

        <h3>Monitoring</h3>
        <ul>
          <li>Mental status/sedation level; fall risk</li>
          <li>BP/HR if giving parenteral doses</li>
          <li>Symptom response (nausea score, ability to hydrate/retain PO)</li>
        </ul>

        <div class="rule"></div>

        <h3>At-sea considerations</h3>
        <ul>
          <li>Favor non-sedating strategies when feasible (hydration, small sips, environmental control); use lowest effective dose</li>
          <li>Document dose/time clearly; avoid double-dosing when multiple providers involved</li>
          <li>For ongoing vomiting: consider dehydration risk and need for escalation/IV fluids per context</li>
        </ul>

        <div class="rule"></div>

        <h3>Online-only references</h3>
        <ul>
          <li><a href="https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/dimenhydrinate-labelling-standards-non-prescription-drugs.html" target="_blank" rel="noopener">Health Canada dimenhydrinate labelling standard (dose guidance)</a></li>
        </ul>
      </div>

      <p class="foot">
        Verify dosing and indications against current clinical guidelines.
      </p>
    </section>
  </main>
</body>
</html>
